|
Volumn 373, Issue 9673, 2009, Pages 1414-
|
Novartis under fire for accepting new reward for old drug.
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIMALARIAL AGENT;
ARTEMETHER LUMEFANTRINE COMBINATION;
ARTEMETHER-LUMEFANTRINE COMBINATION;
ARTEMISININ DERIVATIVE;
ETHANOLAMINE DERIVATIVE;
FLUORENE DERIVATIVE;
AWARDS AND PRIZES;
DRUG APPROVAL;
DRUG COMBINATION;
DRUG INDUSTRY;
ECONOMICS;
ETHICS;
HUMAN;
NOTE;
ORGANIZATION AND MANAGEMENT;
ANTIMALARIALS;
ARTEMISININS;
AWARDS AND PRIZES;
DRUG APPROVAL;
DRUG COMBINATIONS;
DRUG INDUSTRY;
ETHANOLAMINES;
FLUORENES;
HUMANS;
|
EID: 65549145032
PISSN: None
EISSN: 1474547X
Source Type: Journal
DOI: 10.1016/S0140-6736(09)60804-7 Document Type: Note |
Times cited : (8)
|
References (0)
|